A symptom support and palliative care special interest group just approved by the TSANZ Board is believed to be the first SIG of its kind in respiratory societies around the world. The multidisciplinary SIG aims to improve the care of patients with life-limiting lung diseases such as COPD, pulmonary fibrosis and pulmonary hypertension. According to ...
Already a member?
Enter your email to keep reading.